Silk Way West Airlines to enter the global pharmaceutical logistics market with GDP certification

Share on facebook
Share on twitter
Share on linkedin

Baku-based Silk Way West Airlines has been awarded Good Distribution Practice (GDP) certification. To further improve the company’s capacity in reliably handling time- and temperature-sensitive cargo, the carrier has successfully completed an in-depth GDP audit by Global Cold Chain Consultants, a trusted external party with a strong track record in the pharmaceutical industry.

This is a critical step in strengthening and expanding the airline’s offering to the pharmaceutical sector. Being GDP certified, Silk Way West Airlines now intends to extend its product line in transportation of medical goods and pharmaceutical logistics services.

Silk Way West Airlines’ internal procedures have been upgraded in accordance with GDP principles, and the company’s entire staff has been appropriately trained. Moreover, the carrier conducted a thermal mapping of its fleet and the extensive temperature-controlled storage facilities at its main hub in Baku to ensure the integrity of these processes. As a result, staff, equipment, and facilities are all aligned to deliver superior performance.

“Obtaining the GDP certification proves the readiness of Silk Way West Airlines in taking a leading role in global distribution of medical supplies,” said Mr. Wolfgang Meier, CEO and President of Silk Way West Airlines, emphasizing the importance of this achievement in entering the pharmaceutical logistics market.

According to Mr. Aydin Huseynov, Silk Way West Airlines’ Vice President for Global Cargo Logistics & Standards, GDP certification is an important step in upgrading the airline’s carriage capabilities for all pharmaceutical products, as well as ensuring that the required storage services are in place.

“We believe that these efforts focused on ensuring the highest standards in logistics will take the company to the next level in management of time- and temperature-sensitive goods,” said Mr. Huseynov.

Good Distribution Practice (GDP) is a standard based on principles adopted by the European Union and recommended by the World Health Organization. In line with these requirements, medicines are to be obtained from a licensed supply chain and stored, transported and handled under suitable conditions.

Latest News

Advertisements